ÂÜÀòÂÒÂ×

Professor Andrew Lloyd graduated from Robinson College, the University of Cambridge in 1986 with a degree in Natural Sciences, specializing in bioorganic chemistry, biochemistry, and pharmacology. He completed his Ph.D. in biopharmaceutics and was appointed to the academic staff in the Department of Pharmacy, the University of Brighton as a Lecturer in Pharmaceutical Sciences in 1989 and promoted to Senior Lecturer in 1993. He was made Reader in Biopharmaceutical Sciences and elected to Fellowship of the Royal Society of Chemistry in 1998 and promoted to Professor of Biomedical Materials in 2000.

He was appointed as Joint Head of Research with responsibility for strategic planning in the School of Pharmacy and Biomolecular Sciences in 2000, Dean of the Faculty of Science and Engineering in 2003, Dean of the College of Life, Health and Physical Sciences in 2014, and Associate Pro-Vice-Chancellor (Academic Operations) in July 2017. He was interim Pro-Vice-Chancellor (Research and Enterprise) for 6 months in 2016 and was appointed to his present role as Pro-Vice-Chancellor (Academic Operations) in October 2019.

Andrew Lloyd

He was awarded the University of Brighton Patani Gold Medal for Pharmaceutical Research in 1990, the University of Brighton Chairman’s Award for Innovation in 1996 and 2005, the Lilly Prize for Pharmaceutical Excellence in 1999, the Royal Pharmaceutical Society of Great Britain's (RPSGB) Conference Science Award in 2000, the United Kingdom Society for Biomaterials (UKSB) Biocompatibles’ Endowed Lectureship in 2005. He was the British Pharmaceutical Conference Science Chair in 2008.

Andrew's primary research interests include the development and evaluation of novel materials for drug delivery and medical device applications. At present, his research focuses on the development of novel contact lens materials to improve long-term on-eye comfort. His research has been funded by EPSRC, BBSRC, NHS, Royal Society, European Union, and various international pharmaceutical and medical device companies. He has published over 300 articles and was formerly Consultant Editor for 'Drug Discovery Today' and 'Pharmaceutical Science & Technology Today' and co-edited the undergraduate textbook ‘Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists’.

Andrew previously served as a Member of the Council for the UK Society for Biomaterials, Member of the Institute of Materials, Mining and Mineralogy Biomedical Division Biomaterials Committee, Member of the RSC Biomaterials Chemistry Group Committee, and is presently a member of the EPSRC Peer-review Council. He also serves on the editorial boards of Journal of Biomaterials Science (Polymer Edition) and Expert Review of Medical Devices.

He has acted in an advisory capacity for a number of pharmaceutical and medical device companies and was formerly a director of a small biotechnology company 'Cellective Ltd', which undertook contract research related to in vitro drug adsorption and the assessment of the biological compatibility of biomedical material.

Finally, he has held a number of voluntary educational positions including member of the Board of Governors of Seaford Head Community College (2011 – 2012); Chair of Seaford Head Academy Trust (2012 – 2015); Member of the Board of Trustees of the Blond McIndoe Research Foundation (2013 – 2016); Member of the Western Sussex Hospitals Governors (2015 – 2017) and Member of the Board of Trustees of Bede’s Independent School (2016 – date).